Among them, bladder urothelial carcinoma, cholangiocarcinoma, breast invasive carcinoma, COAD, EAC, KIRP, LUSC, PRAD, GBM, HINSC, LIHC, STAD, and UCEC all showed significant levels of DLL3 expression. This evidence concerns the gene DLL3 and invasive breast carcinoma.